Zhendong Pharmacy released its performance for the first three quarters, with a net profit attributable to the parent company of 20.3641 million yuan, a decrease of 49.25%
Zhendong Pharmacy released its Q3 2025 report, with operating revenue for the first three quarters at 2.215 billion yuan, a year-on-year decrease of 2.42%. The net profit attributable to the parent company was 20.3641 million yuan, a year-on-year decline of 49.25%. The net profit after deducting non-recurring gains and losses was 507,500 yuan, a year-on-year increase of 101.67%. The basic earnings per share were 0.0203 yuan
According to the Zhitong Finance APP, Zhendong Pharmacy (300158.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 2.215 billion yuan, a year-on-year decrease of 2.42%. The net profit attributable to shareholders of the listed company was 20.3641 million yuan, a year-on-year decrease of 49.25%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 507,500 yuan, a year-on-year increase of 101.67%. The basic earnings per share were 0.0203 yuan
